|
Market Closed -
Nasdaq
04:00:00 07/10/2025 HKT
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 08/10/25 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 07/10/25 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 305M 266M 251M 228M 427M 29.25B 429M 3.01B 1.16B 14.87B 1.15B 1.12B 47.85B | P/E 2023 |
-4.41x | P/E 2024 | -1.85x |
|---|---|---|---|---|---|
| Enterprise Value | 281M 245M 231M 210M 393M 26.95B 395M 2.77B 1.07B 13.7B 1.06B 1.03B 44.08B | EV / Sales 2023 |
13,839,720x | EV / Sales 2024 | 4,215,542x |
| Free-Float |
98.42% | Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: scPharmaceuticals Inc.
| 1 year | 5.61 |  | 5.7 |
| 3 years | 1.94 | | 7.37 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 07/10/2025 |
| Director of Finance/CFO | 50 | 07/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 07/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 07/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 07/10/2025 |
| Director/Board Member | 50 | 07/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/10/25 | Issuer sale | Director | 72,174 | 0.1442% | ||
| 7/10/25 | Issuer sale | Director | 84,422 | 0.1687% | ||
| 7/10/25 | Issuer sale | Director | 49,750 | 0.0994% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +0.71% | -22.22% | 305M | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.03% | +2.93% | +22.80% | +38.59% | 360.2B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.59% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 13.59 11.85 11.19 10.16 19.04 1.3K 19.12 134.06 51.73 663.13 51.06 49.93 2.13K | 36.33 31.68 29.91 27.16 50.9 3.49K 51.11 358.33 138.28 1.77K 136.48 133.45 5.7K |
| Net income | -54.81M -47.79M -45.13M -40.98M -76.78M -5.26B -77.1M -541M -209M -2.67B -206M -201M -8.6B | -85.15M -74.25M -70.11M -63.66M -119M -8.17B -120M -840M -324M -4.15B -320M -313M -13.37B |
| Net Debt | -36.72M -32.02M -30.24M -27.46M -51.44M -3.52B -51.66M -362M -140M -1.79B -138M -135M -5.76B | -23.98M -20.91M -19.75M -17.93M -33.6M -2.3B -33.74M -237M -91.28M -1.17B -90.09M -88.09M -3.76B |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Select your edition
All financial news and data tailored to specific country editions
